Compare Liquidia Corporation Common Stock (LQDA) vs Symbotic Inc (SYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Symbotic Inc — how do they compare? Liquidia Corporation Common Stock trades at $34.2 (market cap $3.04B), while Symbotic Inc trades at $37.1 (market cap $4.92B). The key difference: Symbotic Inc is the larger of the two by market cap, and Liquidia Corporation Common Stock is trading nearer its 52-week high, Symbotic Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Symbotic Inc for 24 Days on average.
| LQDA | SYM | |
|---|---|---|
Market Cap | $3.04B | $4.92B |
Volume | 21,111,778 | 1,694,503 |
Sector | Health | Industrials |
52-Week High | $91.03 | $87.30 |
52-Week Low | $22.02 | $37.90 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $2.94B | $3.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Symbotic (SYM) trades at $40.89, showing modest daily gains but remains in a bearish technical trend with key support at $40. The company reported negative net income of -$16.94M for 2025 despite $2.25B revenue, though 2026 projections show potential profitability. Analyst consensus remains bullish with a $60.33 price target, while recent news highlights the company's $22.5B backlog and AI-driven warehouse automation growth potential.
SYM presents a high-risk growth opportunity with significant upside potential if execution improves, but faces challenges with profitability and customer concentration. The stock's elevated valuation multiples require strong future earnings delivery to justify current levels, making it suitable for investors comfortable with volatility and long-term automation trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Symbotic Inc
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →
